Bench mark Assignment Assignment Instructions The purpose of this assignment is to identify a clinical practice guideline in your specialty area. You will be challenged to evaluate this guideline and discuss its use in clinical practice. This assignment is due at the end of Week 8 but can be completed anytime during this course. This assignment requires a considerable amount of time for completion. Do not wait until week 8 to begin this assignment. Choose a health problem that you may commonly see in primary care nurse practitioner practice. Describe the health problem and recommended medical management for it. Research published clinical practice guidelines and evaluate the practice guideline you have selected based on the components listed in the Clinical Practice Guideline Template below. Clinical Practice Guideline Prompts: HEALTHCARE PROBLEM IDENTIFIED: Briefly describe the health problem you have identified. Include a discussion of morbidity, mortality, epidemiology and pathophysiology related to this health problem PRACTICE GUIDELINE: Describe the clinical practice guideline used for this problem. Reflect on the questions included. Expand on your answer using support from evidence · Does the clinical practice guideline adequately address the health problem? Describe. · Is this practice guideline based on current evidence (within 5 years)? What is the strength of this evidence? · Does this clinical practice guideline adequately direct the healthcare provider in the management of a patient with this problem? · How effective is this clinical guideline in the management of patients with this healthcare problem? Think about how you would assess the effectiveness of patient management. ANALYSIS: Think about future healthcare needs of patients with this problem, changing demographics, and changes in healthcare policies. Address these questions. · Does this clinical practice guideline need revision(s)? Please explain your answer in detail. · If you were going to revise this clinical practice guideline, what would you change? What evidence would you use to base your changes on? · How might changes in US demographics and healthcare reform affect this clinical practice guideline? · What strategies would you use to increase the likelihood that a new or modified clinical practice guideline would be adopted and used in clinical practice? EVALUATION How would you determine its effectiveness of this revised clinical practice guideline in directing care for patients with the identified health problem? Outline the steps you might employ. LEARNING POINTS (3-5 bullet points outlining key learning in this case.) REFERENCES (APA formatting, current within past 5 years.)

Clinical Practice Guidelines in Primary Care Nurse Practitioner Practice


Clinical practice guidelines (CPGs) play a crucial role in guiding healthcare providers in delivering high-quality patient care. These guidelines provide evidence-based recommendations for the management of specific health problems, ensuring that healthcare practitioners follow a standardized approach. In this benchmark assignment, we will explore the use of CPGs in primary care nurse practitioner practice, focusing on the evaluation and critique of a selected guideline for a common health problem.

Healthcare Problem Identified

For the purpose of this assignment, let us consider the health problem of type 2 diabetes mellitus (T2DM). T2DM is a chronic metabolic disorder characterized by elevated blood glucose levels resulting from insulin resistance and inadequate insulin secretion (American Diabetes Association, 2021). It has become increasingly prevalent worldwide, posing significant challenges in primary care settings.

T2DM carries a considerable burden in terms of morbidity and mortality. Individuals with T2DM are at increased risk of developing various complications such as cardiovascular disease, neuropathy, nephropathy, and retinopathy (American Diabetes Association, 2021). These complications can lead to significant morbidity and early mortality. Epidemiologically, T2DM affects millions of individuals globally, with its prevalence steadily rising, primarily due to aging populations, sedentary lifestyles, and obesity (American Diabetes Association, 2021). The pathophysiology of T2DM involves impairments in insulin sensitivity and/or beta-cell function, leading to hyperglycemia and subsequent organ damage (American Diabetes Association, 2021).

Practice Guideline

The clinical practice guideline selected for evaluation is the “Clinical Practice Recommendations for the Management of Type 2 Diabetes Mellitus” by the American Diabetes Association (ADA, 2021). This guideline provides comprehensive recommendations for the management of T2DM, including the diagnosis, treatment, and monitoring of patients with this condition.

First, we will assess whether the selected guideline adequately addresses the health problem. The ADA guideline covers various aspects of T2DM management, including screening and diagnosis criteria, glycemic control targets, pharmacological and non-pharmacological interventions, and monitoring parameters (ADA, 2021). The guideline addresses the key components necessary for effective management of T2DM in primary care practice.

Next, we will consider the currency and strength of evidence upon which the guideline is based. The ADA guideline is revised annually, incorporating the most recent evidence available. Therefore, it satisfies the criterion of being based on current evidence within the last five years. The strength of the evidence is evaluated using a grading system that considers the quality and relevance of the supporting studies (ADA, 2021). The ADA guideline provides recommendations based on a variety of well-conducted clinical trials, systematic reviews, and expert consensus.

In terms of directing healthcare providers in the management of patients with T2DM, the ADA guideline offers clear, concise, and practical recommendations. It emphasizes the importance of individualized care, considering patient preferences, comorbidities, and psychosocial factors (ADA, 2021). Additionally, the guideline outlines the stepwise progression of pharmacological therapy and provides algorithms for treatment intensification based on glycemic control targets (ADA, 2021). These strategies ensure that healthcare providers have a structured approach to managing patients with T2DM.

Effectiveness of the clinical guideline in managing patients with T2DM is a critical consideration. Several studies have shown that adherence to diabetes management guidelines, including those provided by the ADA, can improve glycemic control, reduce complications, and enhance patient outcomes (Huang et al., 2018; Vinter et al., 2020). However, the effectiveness of the guideline can vary depending on factors such as patient adherence, healthcare provider knowledge and skills, and available resources in the clinical setting.